Thompson Davis & Co’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
$43K Buy
2,600
+850
+49% +$14.4K 0.09% 222
2018
Q2
$29K Buy
+1,750
New +$28.3K 0.07% 267
2018
Q1
Sell
-500
Closed -$9K 693
2017
Q4
$9K Buy
+500
New +$11.1K 0.02% 433
2016
Q2
Sell
-515
Closed -$21K 1142
2016
Q1
$21K Buy
515
+127
+33% +$4.73K 0.03% 446
2015
Q4
$14K Buy
388
+127
+49% +$4.59K 0.02% 574
2015
Q3
$8K Buy
261
+2
+0.8% +$68 0.01% 724
2015
Q2
$9K Buy
259
+2
+0.8% +$67 0.01% 742
2015
Q1
$9K Sell
257
-254
-50% -$8.85K 0.01% 761
2014
Q4
$18K Buy
511
+4
+0.8% +$135 0.02% 548
2014
Q3
$17K Buy
507
+3
+0.6% +$102 0.02% 519
2014
Q2
$17K Buy
504
+4
+0.8% +$137 0.02% 416
2014
Q1
$18K Hold
500
0.03% 399
2013
Q4
$18K Buy
+500
New +$18.4K 0.03% 360

Other funds holding ACH

Thompson Davis & Co's ACH Position: Q3 2018 in Review

Thompson Davis & Co increased its Accendra Health (ACH) stake by 49% in Q3 2018, buying an estimated $14.4K and bringing the position to 2,600 shares worth $43K. The position accounts for 0.09% of the portfolio, ranked #222.

Thompson Davis & Co first reported a position in ACH in Q4 2013 and has held it in 13 quarters since. 219 funds tracked by Wall St. Rank hold ACH as of Q3 2018.

  • Thompson Davis & Co held 2,600 shares of Accendra Health worth $43K as of Q3 2018.
  • Thompson Davis & Co bought 850 Accendra Health shares in Q3 2018, an estimated $14.4K.
  • Accendra Health made up 0.09% of Thompson Davis & Co's portfolio in Q3 2018, its #222 holding.
  • Thompson Davis & Co first reported a position in Accendra Health in Q4 2013 and has held it in 13 quarters since.
  • 219 funds tracked by Wall St. Rank held Accendra Health as of Q3 2018.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.